Search

NLS-technologies By Metatron 4025 Hunter For Malignant Pancreatic Neoplasms

Author:Thomas  UpdateTime:2016-10-07

    Malignant pancreatic neoplasms incidence in Russia was 9.2 cases per 100 thousand people (3% of all malignant neoplasms) in 2009. High incidence rate of malignant pancreatic tumors is peculiar to group of people above 75 (45.8%). On the other hand constantly improving methods of surgical treatment require more precise and well-timed diagnosing of pancreas diseases. It is especially pressing at pancreas cancer, diagnosing of which still remains one of the most difficult tasks of the modern diagnostics.

    Low percentage of pancreas cancer operability (less than 10% on the average) and unsatisfactory distant results of extensive and standard gastro-pancreatic-oduodenal exsection are related, first of all, to diffused character of the disease in patients at the moment of surgical intervention. That is why a precise diagnostics of pancreas cancer at the early stages is the necessary condition for successful treatment. Today in the well-equipped medical institution search of nidal affection of pancreas is carried out with the help of such standard methods of visualization as ultrasound, CT and MRI, their diagnostic value for evaluation of pancreas condition is unquestionable. At the same time, recent development of new computed NLS-technologies by metatron 4025 hunter forces us to reconsider importance of this method in search of space-occupying processes in pancreas and puts this method forward. It became possible after introduction of new NLS-technologies, such as three-dimensional NLS-graphy, ultramicro-scanning with spectral-entropic analysis (SEA), NLS-angiography and others into a practice.

    These technologies provide very high space resolution of NLS-research, allow to evaluate morphological character of neoplasms non-invasively, acquire precise topographically oriented images of various blood vessels.

Views:  [Printing]  [Close]    

This article is provide from [Metatron 4025 hunter],please indicate the source address reprinted:http://www.healthycarer.com/news/nls-knowledge/1400.html